K020806

Substantially Equivalent

ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY

Applicant: Bayer Corp.
Product code: LOJ
Advisory panel: Immunology
Date received: 2002-03-12
Decision date: 2002-03-27
Decision: Substantially Equivalent
Clearance type: Special
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.